e-learning
resources
Virtual 2021
06.09.2021
Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Hypoxia dampens the allergen-dependent adaptive immune response and ameliorates allergic asthma in vivo
M. Hochgerner (Graz, Austria), E. Sturm (Graz, Austria), D. Schnoegl (Graz, Austria), G. Kwapiszewska (Graz, Austria), H. Olschewski (Graz, Austria), L. Marsh (Graz, Austria)
Source:
Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Session:
Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Session type:
E-poster
Number:
2528
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Hochgerner (Graz, Austria), E. Sturm (Graz, Austria), D. Schnoegl (Graz, Austria), G. Kwapiszewska (Graz, Austria), H. Olschewski (Graz, Austria), L. Marsh (Graz, Austria). Late Breaking Abstract - Hypoxia dampens the allergen-dependent adaptive immune response and ameliorates allergic asthma in vivo. 2528
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Late Breaking Abstract - Formaldehyde inhalation impairs immune system and may affects severity of allergic disease
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017
Late Breaking Abstract - IL-33 drives influenza-induced exacerbations of asthma by halting anti-viral and Th1 responses
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017
Late Breaking Abstract - Systemic IL-26 correlates with improved asthma control in children with allergic sensitization
Source: International Congress 2018 – Molecular and cellular determinants of the developing lung
Year: 2018
LSC - 2019 - Azithromycin modulates viral-induced asthma exacerbation by targeting the innate immune response
Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes
Year: 2019
Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
Late Breaking Abstract - Human lung microbiota-driven differential innate immune landscape
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
Late Breaking Abstract - B cell adaptive immune profile in emphysema-predominant COPD
Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2019
Presentation by an expert: Role of basophils in allergic inflammation and protective immunity
Source: Lung Science Conference 2014 - Lung Inflammation and Immunity
Year: 2014
Relevance of innate immune responses to chronic airway diseases
Source: Annual Congress 2008 - The battle between environmental “invaders” and airway epithelial defences
Year: 2008
Allergen avoidance improves allergic inflammation control through regulation of the AQP5-EGFR-mucin pathway
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Aerobic training reverses the inhibition in the expression of glucocorticoid receptors and decreases the Th2 allergic inflammation in asthma model
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
IL-10 and IL-1ra mediates OVA-induced Th2 airway allergic response at short and long-term
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Oral presentation: Role of B-lymphocytes in a mouse model of chemical-induced asthma Innate immunity and the development of atopy
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010
Childhood asthma and humoral immune response
Source: Eur Respir J 2005; 26: Suppl. 49, 377s
Year: 2005
LATE-BREAKING ABSTRACT: IL33 drives humoral and cellular immune response in influenza-induced severe exacerbation of experimental asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
Late Breaking Abstract - Efficacy of CSJ117 on allergen-induced asthmatic responses in mild atopic asthma patients
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020
Master switches of T-cell activation and differentiation
Source: Eur Respir J 2007; 29: 804-812
Year: 2007
Dysregulation of type 2 innate lymphoid cells and Th2 cells impairs pollutant-induced allergic airway responses
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
Late Breaking Abstract - The “one airway, one disease” concept at the light of Th2 inflammation
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017
Late Breaking Abstract - GATA-3 in lung CD4+T cells drives Interleukin-10 deficiency-induced lung inflammation in asthma
Source: Virtual Congress 2020 – New insights into asthma immunology: in mouse and men
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept